Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bullock

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Organic Letters|December 9, 2010
Guest-accelerated molecular rotorBrent E Dial, Roger D Rasberry, Brooke N Bullock, et al.
The Biochemical Journal|January 7, 2017
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16Sarah E Dixon-Clarke, Saifeldin N Shehata, Tobias Krojer, et al.
Cancer Research|October 1, 1992
Cyclophosphamide resistance in medulloblastomaH S Friedman, O M Colvin, S H Kaufmann, et al.
Cancer Research|July 20, 2007
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activityVanda Pogacic, Alex N Bullock, Oleg Fedorov, et al.
The Journal of Biological Chemistry|November 5, 2014
Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiationDaniel Horbelt, Jan H Boergermann, Apirat Chaikuad, et al.
Journal of Molecular Biology|June 29, 2013
Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligasesJoão R C Muniz, Kunde Guo, Nadia J Kershaw, et al.
The Biochemical Journal|October 1, 2017
Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligasesDaniel M Pinkas, Caroline E Sanvitale, Joshua C Bufton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2018
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitorsChalada Suebsuwong, Daniel M Pinkas, Soumya S Ray, et al.
The American Journal of Surgical Pathology|June 15, 2018
Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1Ashley Volaric, Ryan Gentzler, Richard Hall, et al.
Bone|March 20, 2018
Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disordersAiko Machiya, Sho Tsukamoto, Satoshi Ohte, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Organic Letters|December 9, 2010
Guest-accelerated molecular rotorBrent E Dial, Roger D Rasberry, Brooke N Bullock, et al.
The Biochemical Journal|January 7, 2017
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16Sarah E Dixon-Clarke, Saifeldin N Shehata, Tobias Krojer, et al.
Cancer Research|October 1, 1992
Cyclophosphamide resistance in medulloblastomaH S Friedman, O M Colvin, S H Kaufmann, et al.
Cancer Research|July 20, 2007
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activityVanda Pogacic, Alex N Bullock, Oleg Fedorov, et al.
The Journal of Biological Chemistry|November 5, 2014
Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiationDaniel Horbelt, Jan H Boergermann, Apirat Chaikuad, et al.
Journal of Molecular Biology|June 29, 2013
Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligasesJoão R C Muniz, Kunde Guo, Nadia J Kershaw, et al.
The Biochemical Journal|October 1, 2017
Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligasesDaniel M Pinkas, Caroline E Sanvitale, Joshua C Bufton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2018
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitorsChalada Suebsuwong, Daniel M Pinkas, Soumya S Ray, et al.
The American Journal of Surgical Pathology|June 15, 2018
Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1Ashley Volaric, Ryan Gentzler, Richard Hall, et al.
Bone|March 20, 2018
Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disordersAiko Machiya, Sho Tsukamoto, Satoshi Ohte, et al.
Pageof 22